Skip to main content
. 2014 May 8;9(5):e96822. doi: 10.1371/journal.pone.0096822

Table 2. Genes differently methylated in case-control studies from different kinds of leukemia subjects.

Gene∼Disease Studies Overall OR (95% CI)a P value
CDKN2A∼AML 5 8.63 [1.52, 48.91] 0.01
CDKN2B∼AML 3 31.92 [1.37, 742.18] 0.03
CDKN2A∼CML 3 0.82 [0.38, 1.74] 0.6
CDKN2A∼CLL 3 2.04 [0.74, 5.59] 0.17
ID4∼AML 3 87.52 [16.05, 477.38] <0.01
a

Odds ratio (OR) describes the likelihood of gene methylation observed in leukemia cases compared to controls.